Cytokinetics reported that its drug aficamten significantly improved symptoms in patients with non-obstructive hypertrophic cardiomyopathy, advancing prospects for FDA approval. In parallel, Wolfson ...
Please provide your email address to receive an email when new articles are posted on . Updated guidance highlights best practices for fetal echocardiography to diagnose congenital heart disease.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results